Barclays PLC
30 September 2003
30 September 2003
Notification of directors' interests: Companies Act 1985 s.329
The trustee of the Barclays Qualifying Employee Share Ownership Trust (the '
Quest') notified the Company on 29 September 2003 that it subscribed for a total
of 18,691,316 Barclays PLC ordinary shares on 29 September 2003 at a price of
471.75p per share. (The Quest is a trust which distributes shares to employees
of the Barclays Group on the exercise of options granted under the Barclays PLC
1991 SAYE Share Option Scheme, the Barclays Group SAYE Share Option Scheme and
the Woolwich plc Sharesave Scheme (the 'Schemes')).
Following this transaction, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 100,851,774 ordinary shares in Barclays PLC. Sir
Peter Middleton, Mr M W Barrett, Mr C J Lendrum and Mr J S Varley, directors of
Barclays PLC, are amongst the potential beneficiaries under these trusts and are
therefore regarded for Companies Act purposes as being interested in the
Barclays PLC ordinary shares held in them.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.